FDAnews
www.fdanews.com/articles/132156-risk-of-bleeding-among-patients-taking-two-anti-platelet-drugs

Risk of Bleeding Among Patients Taking Two Anti-Platelet Drugs

November 23, 2010
Dual antiplatelet therapy — treatment with the medications clopidogrel and aspirin together to prevent blood clots — poses a clinically significant risk of hemorrhage that should be considered before prescribing, according to a report in the November 22 issue of Archives of Internal Medicine.
ScienceDaily